Aniracetam – What it is

Here is what Wikipedia has to say about aniracetam, which was developed in the 1970’s by  by Hoffmann-La Roche:
Aniracetam (DraganonSarpulAmpametMemodrinReferan), also known as N-anisoyl-2-pyrrolidinone, is an ampakinenootropic of the racetam chemical class purported to be considerably more potent than piracetam. It is lipid-soluble and has possible cognition-enhancing effects. It has been tested extensively in animals, Alzheimer’s patients, and temporarily impaired healthy subjects. It has shown potential as an anxiolytic in three clinical animal models. It is sold in Europe as a prescription drug,[1] but it is not approved by the Food and Drug Administration for use in the United States Aniracetam has also been shown to positively modulate the AMPA receptor and was used as the parent compound to derive a class of drugs known as the ampakines that are being investigated as nootropics and neuroprotective drugs for the treatment of Alzheimer’s disease and other neurodegenerative conditions.


Aniracetam – What it Means

Aniracetam is fat-soluble and more potent than its predecessor.  As a cognition-enhancing drug, It helps you “think better” and has been extensively tested on animals, Alzheimer’s patients, and those under the influence of an intentionally impairing condition (think drug abusers, drunks, and stoners).  Aniracetam inhibits anxiety (anxiolytic) which may help you “feel better” emotionally and may contribute to the long-term improvement of brain functions and the halting, or even reversal, of neurological diseases.  Aniracetam is NOT approved for use by the FDA, meaning that there are few specific claims beyond those demonstrated in laboratory conditions.  It exists in the shady area between demonstrating proven benefits and no proven contraindications.  As with any nootropic, one should be prepared to request MSDS (material safety data sheets) from any provider with whom one has not established a trusting relationship.


ANIRACETAM – What it “Does”

Aniracetam has been shown to improve mood, focus, memory, and learning.  It is efficacious in treating brain trauma, dementia, and Alzheimer’s disease.  Aniracetam is one of the lowest-cost racetams with the biggest bang per buck.  It is a great “starter nootropic,” as the effects are immediate and obvious.  The half-life in your system is 1-1/2 to 2 hours and a typical dose is 750 mg, twice a day.  This dose would be taken upon waking and again, at lunch time.  Aniracetam should always be taken with a source of choline to avoid headaches associated with depleted systemic choline levels. It is considered somewhat stimulating and should not be taken in the hours before one wishes to sleep.  In extreme situations, Aniracetam may cause irritability and anxiety when combined with alcohol or other mood-altering drugs.


Disclaimer: Please do not substitute our information for your own due diligence.  Research and understand this product and what it can do for you and be responsible for your body’s limitations. We are not responsible for any adverse reactions to our products as there may be unknown contraindications when combining with alcohol or other drugs.  This product is not intended to diagnose, treat, cure or prevent any disease. These statements have not been evaluated by the Food & Drug Administration. If you have any medical conditions, please consult a medical professional before buying.

Smart Drugs for Smart People